Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Non-invasive Assessment
100%
Dynamic Contrast-enhanced MR Imaging
100%
Vascular Inflammation
100%
Pioglitazone
100%
FDG Positron Emission Tomography/computed Tomography
100%
Computed Tomography Contrast
100%
Dynamic Contrast-enhanced Magnetic Resonance Imaging (DCE-MRI)
50%
18F-fluorodeoxyglucose Positron Emission Tomography/computed Tomography (18F-FDG PET/CT)
50%
Standardized Uptake Value
37%
Inflammation
25%
Anti-inflammatory Effect
25%
Area under the Curve
25%
Aorta
25%
Serum Metabolic Parameter
25%
High Risk
12%
Treatment Group
12%
Imaging Techniques
12%
Correlation Analysis
12%
Balloon
12%
Immunoreactivity
12%
Peroxisome Proliferator-activated Receptor
12%
Treatment Initiation
12%
Non-invasive Imaging
12%
Histological Analysis
12%
New Zealand White Rabbit
12%
Macrophages
12%
Imaging Results
12%
Magnetic Resonance Imaging Analysis
12%
Histopathological Correlation
12%
Endothelial Denudation
12%
Anti-inflammatory Properties
12%
Multi-method
12%
Oxidized Phospholipids
12%
Neovessel
12%
Underlining
12%
Inflammation in Atherosclerosis
12%
Macrophage Density
12%
Value Density
12%
Hyperlipidemic Diet
12%
Differences between Groups
12%
Positron Emission Tomography/computed Tomography Imaging
12%
Anti-atherosclerotic
12%
Medicine and Dentistry
Magnetic Resonance Imaging
100%
Positron Emission Tomography-Computed Tomography
100%
Vasculitis
100%
Pioglitazone
100%
Fluorodeoxyglucose F 18
50%
Dynamic Contrast-Enhanced MRI
50%
Atherosclerotic Plaque
50%
Standardized Uptake Value
37%
Inflammation
37%
Macrophage
25%
Antiinflammatory Activity
25%
Area under the Curve
25%
Hyperlipidemia
12%
Imaging Technique
12%
Atherosclerosis
12%
Immunoreactivity
12%
Anti-Inflammatory Drug
12%
Phospholipid
12%
Peroxisome Proliferator Activated Receptor Gamma Agonist
12%
Treatment Group
12%
Immunology and Microbiology
Positron Emission Tomography-Computed Tomography
100%
Magnetic Resonance Imaging
100%
Leporidae
100%
Vasculitis
100%
Inflammation
60%
Macrophage
40%
Antiinflammatory Activity
40%
Immunoreactivity
20%
Peroxisome
20%
Agonist
20%
Atherosclerosis
20%
New Zealand White (Rabbit)
20%
Pharmacology, Toxicology and Pharmaceutical Science
Leporidae
100%
Vasculitis
100%
Pioglitazone
100%
Fluorodeoxyglucose F 18
50%
Atherosclerotic Plaque
50%
Inflammation
37%
Antiinflammatory Activity
25%
Hyperlipidemia
12%
Atherosclerosis
12%
Anti-Inflammatory Drug
12%
Phospholipid
12%
New Zealand White (Rabbit)
12%
Peroxisome Proliferator Activated Receptor Gamma Agonist
12%
Treatment Group
12%
Veterinary Science and Veterinary Medicine
Magnetic Resonance Imaging
100%
Leporidae
100%
Positron Emission Tomography-Computed Tomography
100%
Inflammation
100%
Macrophage
40%
Peroxisome Proliferator-Activated Receptor Gamma
20%
Hyperlipidemia
20%